PharmaShots | Incisive News in 3 Shots

Subscribe Now

FDA Formulation

The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq

The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq

March 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us